Barclays PLC has disclosed its position in HIPGNOSIS SONGS FUND LTD, as of May 7, 2024. The disclosure indicates that Barclays PLC owns and/or controls 22,128,957 ordinary shares, representing 1.83% of the total relevant securities. Additionally, Barclays PLC holds cash-settled derivatives and stock-settled derivatives, with percentages and details provided in the disclosure.

The dealings by Barclays PLC on May 7, 2024, include both purchases and sales of ordinary shares in HIPGNOSIS SONGS FUND LTD. The disclosure lists the number of securities and the price per unit for each transaction. Furthermore, it details cash-settled derivative transactions, including closing short positions and opening long positions, along with the number of reference securities and price per unit for each transaction.

The disclosure also includes information on stock-settled derivative transactions, such as writing, purchasing, selling, or varying options, and exercising or being exercised against options. It provides details on the nature of the dealings and the number of securities, exercise price per unit, and other relevant information.

Barclays PLC's disclosure does not indicate any indemnity or other dealings arrangements, agreements, arrangements, or understandings relating to options or derivatives. The disclosure concludes with the confirmation that no supplemental form is attached and includes the date of disclosure and contact information for regulatory operations at Barclays PLC.

This disclosure provides transparency regarding Barclays PLC's interests, short positions, and dealings in HIPGNOSIS SONGS FUND LTD, in compliance with Rule 8.3 of the Takeover Code.